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Since Shaw and Maynard1 described the first suc-
cessful operative correction of chronic visceral
ischemia in 1958, surgical techniques of visceral
revascularization have evolved that have a low oper-
ative mortality rate and achieve durable relief of
symptoms.2-6 In our experience over three decades,
transaortic visceral endarterectomy and antegrade
aortovisceral bypass are the preferred revasculariza-
tion techniques. More than 85% of patients
remained cured or improved at 5 years.2 In addition,
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Purpose: Recurrent visceral ischemia after a failed visceral revascularization occurs in up
to one third of patients, yet no comprehensive report has described the management of
this problem. The purpose of this study was to examine the presentation, surgical man-
agement, and outcome of patients with recurrent visceral ischemia.
Methods: Between 1959 and 1997, 109 patients underwent primary visceral revascular-
ization at the University of California, San Francisco. Nineteen patients (17.4%) had
recurrent visceral ischemia (12 chronic visceral ischemia, seven acute visceral ischemia).
Fourteen additional patients with recurrent chronic visceral ischemia were referred after
failed primary revascularization (two patients underwent multiple operations before
referral). Thirty visceral reoperations were performed for recurrent visceral ischemia in
24 patients (10 patients with recurrence at University of California, San Francisco, 14
referred patients). Symptom-free and overall survival rates were determined by life table
analysis.
Results: Of seven patients (6.4%) who had recurrent acute visceral ischemia, six (85.7%)
died of bowel infarction. Twelve patients (11%) had recurrent chronic visceral ischemia.
Patients with recurrent chronic visceral ischemia received their diagnoses earlier and lost
less weight than at their initial presentation (p = 0.004 and 0.001, respectively). Recur-
rent ischemia was associated with younger age, greater weight loss, and modification of
surgical technique at the time of initial operation (p = 0.5, 0.009, and 0.02, respective-
ly). For 20 (90.9%) of the 22 first reoperations, antegrade aortovisceral bypass (n = 10)
or transaortic visceral endarterectomy (n = 10) was used. Multiple techniques (four ante-
grade bypass, two retrograde bypass, one endarterectomy, one anastomotic revision)
were used in the eight second or third reoperations. Postoperative mortality and com-
plication rates were 6.7% and 33.3%, respectively. Symptoms recurred in six of 22
patients (27.3%) after the first reoperation, three of whom were cured or improved after
additional reoperations. The life table symptom-free survival rate after reoperation was
77.3% and 62.8% at 1 and 5 years, respectively. The life table overall survival rate after
reoperation was 74.6% at 5 years.
Conclusions: Recurrent visceral ischemia is not uncommon after primary visceral revas-
cularization. These results show that reoperation for recurrent chronic visceral ischemia
can be accomplished safely and effectively with established revascularization techniques.
Furthermore, after repeat visceral revascularization patients achieve durable relief of
symptoms and have life expectancy rates comparable with those of patients who under-
go primary visceral revascularization.  (J Vasc Surg 1998;27:276-86.)
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others have documented a 3-year 89% cumulative
patency rate of aortovisceral bypass grafts with
objective follow-up with duplex scanning or arteri-
ography.3
Although primary visceral revascularization is
successful in most patients, all methods of operative
revascularization are susceptible to late failures.
Recurrent visceral ischemia has been reported in up
to one third of patients who undergo visceral revas-
cularization.6-8 Although strategies for the manage-
ment of this problem have been suggested,9,10 no
report to date has described the clinical presentation
and management of recurrent visceral ischemia in a
substantial series of patients. In this report we review
our experience with the clinical presentation, surgi-
cal treatment, and outcome of patients with recur-
rent visceral ischemia after primary visceral revascu-
larization.
PATIENTS AND METHODS
The records of 123 patients who underwent vis-
ceral revascularization at the University of Califor-
nia, San Francisco (UCSF) from January 1959
through April 1997 were reviewed. Patients were
identified from a prospectively acquired database of
all vascular surgery procedures performed at UCSF.
All patients included in this study had symptoms
consistent with chronic visceral ischemia and under-
went either primary visceral revascularization, reop-
eration for recurrent visceral ischemia, or both at
UCSF. Specifically excluded were patients who were
undergoing revascularization for visceral artery dis-
ease of nonatherosclerotic cause including arcuate
ligament syndrome, coarctation, vasculitis, aortic
dissection, and mesenteric embolectomy alone with-
out additional reconstruction. Records of primary or
secondary visceral artery operations conducted at
other institutions before referral were obtained.
Follow-up data were collected from hospital and
clinic charts and by telephone interview of the
patients, their families, or referring physicians.
Patients who underwent visceral revasculariza-
tion at UCSF and the visceral operations performed
are summarized in Tables I and II. Of the 109
patients who underwent primary visceral artery
revascularization, durable relief of ischemic symp-
toms was achieved in 90 patients. In 19 patients
(17.4%) symptomatic recurrent visceral ischemia
developed. Ten patients (9.2%) had recurrent chron-
ic visceral ischemia and underwent secondary viscer-
al revascularization. Two additional patients (1.8%)
had recurrent chronic visceral ischemia but did not
undergo a second revascularization procedure.
Seven patients (6.4%) had acute visceral ischemia
and bowel infarction. An additional 14 patients
underwent operations for chronic visceral ischemia
at other institutions and were referred for treatment
of recurrent chronic visceral ischemia. Before refer-
ral one of these 14 patients underwent two visceral
operations, and the other underwent three visceral
operations.
A total of 30 visceral reoperations were per-
formed in 24 patients with recurrent chronic viscer-
al ischemia. Fourteen reoperations were performed
in 10 patients who had their original revasculariza-
tion at UCSF, and 16 reoperations were performed
in 14 patients who had their original visceral revas-
cularization elsewhere. The 30 visceral reoperations
included first (n = 22), second (n = 5), or third (n =
3) reoperations after failed primary or secondary vis-
ceral operations (Table II). Antegrade aortovisceral
bypass grafting or transaortic visceral thromboen-
darterectomy, the procedures of choice for chronic
visceral ischemia at UCSF, were used for most vis-
ceral reoperations. These techniques have been
described in detail.2,11,12
To identify factors associated with recurrent vis-
ceral ischemia among the 109 patients who under-
went primary visceral revascularization at UCSF, the
90 patients who underwent primary visceral revascu-
Table I. Patients who underwent visceral revascu-
larization
Patients Reoperations
No recurrence 90 —
Recurrent chronic visceral ischemia
Primary revascularization at UCSF 12 14
Primary revascularization elsewhere 14 16
Recurrent acute visceral ischemia
Primary revascularization at UCSF 7 (2)*
Total 123 30
*Both patients with acute recurrence underwent graft thrombec-
tomy only.
Table II. Operations for chronic visceral ischemia
at UCSF
No.
Primary revascularization 109
Secondary revascularization
First reoperation 22
Second reoperation 5
Third reoperation 3
Total visceral operations 139
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larization at UCSF and did not have recurrent vis-
ceral ischemia were compared with the 19 patients
who underwent primary visceral revascularization at
UCSF and had recurrent visceral ischemia (acute or
chronic). Groups were compared for differences in
risk factors, clinical presentation, operative details,
and postoperative complications at primary revascu-
larization.
Data were analyzed with the unpaired t test,
Mann-Whitney Rank Sum Test, c contingency
analysis, and Fisher’s exact test (one-tailed) where
appropriate.13 Follow-up data were analyzed in life
table format, and survival curves were generated
with the Kaplan-Meier method.14 All data are pre-
sented as the mean ± SD.
RESULTS
Recurrent chronic visceral ischemia. The clin-
ical profile of 24 patients who underwent reopera-
tion at UCSF for recurrent chronic visceral ischemia
(Table III) was similar to that described for patients
who underwent primary chronic visceral ischemia.15
Most patients were female (87.5%), with a
female/male ratio of 7:1. The mean age at primary
operation was 57.3 years and at first reoperation was
60.2 years. Tobacco use (75%) and hypertension
(58.3%) were also prevalent among patients. Non-
visceral vascular disease (50%) and cardiac disease
(20.8%) were the most frequently associated condi-
tions, and 37.5% of patients had previously under-
gone a peripheral vascular operation. Three patients
underwent resection of ischemic bowel before reop-
eration for recurrent visceral ischemia. None of the
patients who underwent reoperation had undergone
revascularization of all three visceral vessels at their
original operation, and more than half (54.2%) had
only one visceral artery that underwent revascular-
ization.
Twenty-two of the 24 patients with recurrent
chronic visceral ischemia underwent their first vis-
ceral reoperation at UCSF; 10 had undergone pri-
mary visceral revascularization at UCSF, and 12
were patients referred from other institutions. All
patients had abdominal pain that most often was
postprandial (81.8%). Pain and weight loss recurred
1.5 months to 26 years (mean, 35.0 ± 54.2 months)
after the original operation. The interval from the
onset of ischemic symptoms to operation was short-
Table III. Profile of patients who underwent reop-
eration (n = 24)
No. %
Age at primary operation (yr) 57.3 ± 8.2
Age at first reoperation (yr) 60.2 ± 9.1
Sex
Women 21 87.5
Men 3 12.5
Ratio (female/male) 7:1
Risk factors
Diabetes 0 0.0
Smoking 18 75.0
Pack-years 43.0 ± 22.8
Hypertension 14 58.3
Associated illnesses
Peripheral vascular 12 50.0
Cardiac 5 20.8
Renal 1 4.2
Serum creatinine (mg/dl) 0.8 ± 0.2
Pulmonary 1 4.2
Previous surgery
Peripheral vascular 9 37.5
Gastrointestinal tract 11 45.8
Gastrointestinal tract 3 12.5
for ischemia/infarction
No. vessels revascularized at primary operation
1 visceral artery 13 54.2
2 visceral arteries 11 45.8
3 visceral arteries 0 0.0
Mean 1.5 ± 0.5
Table IV. Clinical presentation at first reoperation
(n = 22)
No. %
Symptoms
Symptomatic interval (mo)
At primary operation 11.7±9.8
At reoperation* 3.0±2.9
Abdominal pain pattern
Postprandial 18 81.8
Atypical 4 18.2
None 0 0.0
Other gastrointestinal 17 77.3
symptoms
Physical findings
Abdominal bruit 16 72.7
Abnormal peripheral pulses 11 50.0
Weight loss
At primary operation 18 81.8
Mean (lbs) 29.1±16.6
At reoperation 10 45.5
Mean (lbs)† 9.9±8.4
Preoperative aortography
Visceral arteries involved
Celiac/IMA 1 4.5
SMA/IMA 1 4.5
Celiac/SMA 8 36.4
Celiac/SMA/IMA 12 54.5
Average number 2.5±0.5
of diseased 
viscerals
Renal arteries involved 8 36.4
*p = 0.004 (unpaired t test).
†p = 0.001 (unpaired t test).
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er at reoperation (3.0 ± 2.9 months) than at original
operation (11.7 ± 9.8 months; p = 0.004). Preoper-
ative weight loss was also less at reoperation (9.9 ±
8.4 pounds) than at original operation (29.1 ± 16.6
pounds; p = 0.001; Table IV).
Among the 22 patients undergoing their first vis-
ceral reoperation, 20 (90.9%) had disease involving
both the celiac axis and the superior mesenteric
artery (SMA), and 12 patients (54.5%) had disease
involving the celiac, SMA, and inferior mesenteric
artery (IMA). The average number of diseased vis-
ceral arteries per patient was 2.5 ± 0.5 (Table IV).
Two patients with symptoms of recurrent chron-
ic visceral ischemia did not undergo repeat revascu-
larization. One patient had postprandial pain 6
months after antegrade aortoceliac bypass grafting
and transarterial endarterectomy of the SMA. By
aortography the celiac bypass had a 50% stenosis,
and the SMA was occluded. Nonetheless, her symp-
toms resolved 3 months later, and the patient was
alive 20 years later at last follow-up. One patient
receiving renal dialysis was advised by her primary
physician (without vascular consultation) that no
therapy was available and died after dialysis was elec-
tively withdrawn.
Recurrent acute visceral ischemia. Seven of the
19 patients with recurrent visceral ischemia after pri-
mary visceral revascularization at UCSF had acute
visceral ischemia; three patients had acute ischemia
in the perioperative period after the original proce-
dure, and four patients had acute ischemia 8 months
to 8 years after the original operation. Six (85.7%) of
the seven patients who had acute visceral ischemia
subsequently died of intestinal gangrene; two under-
went thrombectomy of an occluded aortovisceral
bypass grafts and died, two underwent bowel resec-
tion and died, and two had extensive bowel infarc-
tion and died. The lone survivor had acute abdomi-
nal pain 4 months after undergoing antegrade pros-
thetic bypass to the celiac and SMA. Despite a patent
aortovisceral bypass graft, exploratory laparotomy
revealed a segment of infarcted jejunum, which was
resected successfully. The patient had no symptoms
for the next 5 years and then had a fatal stroke. It is
interesting that two of the patients who had recur-
rent acute ischemia had hypercoaguable conditions
and thrombosis of bypass grafts: lupus anticoagulant
in one patient and heparin-induced thrombocytope-
nia in the other.
Reoperative techniques. The 30 visceral artery
reoperations performed in 24 patients with recur-
rent chronic visceral ischemia are summarized in
Table V. Of the 30 procedures, 22 were first reoper-
ations, five were second reoperations, and three were
third reoperations. Visceral revascularization proce-
dures included antegrade aortovisceral bypass (n =
14) and transaortic visceral endarterectomy (n =
11). Other techniques were used in the remaining
five cases (Table V). The mean number of visceral
arteries that underwent revascularization at first (1.6
± 0.7), second (1.6 ± 0.5), or third (1.7 ± 1.1) reop-
eration did not vary. Nineteen celiac arteries, 17
SMAs, and 13 IMAs were repaired.
Of the 22 patients undergoing their first reop-
eration, 20 were treated with transaortic visceral
endarterectomy (n = 10) or antegrade aortoviscer-
al bypass (n = 10). Moreover, the type of revascu-
larization technique (endarterectomy or bypass)
selected for first reoperation was based on the
technique used at the original revascularization
procedure. When the technique used at the origi-
nal procedure was bypass (n = 13), transaortic
endarterectomy was used at first reoperation in
nine (69.2%) patients. Conversely, when the tech-
Table V. Operative details: reoperations for recurrent chronic visceral ischemia
First reoperation (n = 22) Second reoperation (n = 5) Third reoperation (n = 3)
No. % No. % No. %
Visceral technique*
Antegrade bypass 10 45 2 40 2 67
Transaortic endarterectomy 10 45 1 20 0 0
Other† 2 9 2 40 1 33
Arteries repaired
Celiac 15 68 2 40 2 67
SMA 12 55 3 60 2 67
IMA 9 41 3 60 1 33
Mean number of repaired arteries 1.6 ± 0.7 1.6 ± 0.5 1.7 ± 1.1
*Classified according to technique used for celiac and/or SMA if different from technique used for IMA.
†IMA bypass only (n = 2), retrograde SMA bypass (n = 2), thombectomy and anastomotic dilatation (n = 1).
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nique used at the original procedure was
endarterectomy (n = 7), antegrade bypass was
used in six patients (85.7%). The techniques most
often used for visceral reoperation are illustrated in
Figs. 1 and 2.
At second reoperation one patient underwent
transaortic endarterectomy of the celiac artery,
which had not previously undergone operation.
Otherwise, at all other secondary or tertiary reoper-
ations, antegrade bypass (n = 4) was preferred, but
other techniques (retrograde bypass, thrombectomy
and anastomotic revision, IMA graft repair; n = 3)
were also used.
The IMA underwent revascularization during 13
reoperations. IMA revascularization accompanied
antegrade bypass grafting or transaortic endarterec-
tomy of the celiac artery, SMA, or both in eight
reoperations. In five reoperations the IMA was the
only visceral artery that underwent revasculariza-
tion. Transaortic endarterectomy of the IMA was
performed in seven cases. Other techniques includ-
ing bypass grafting and reimplantation were used in
the remaining six cases.
Perioperative mortality data and complica-
tions. Two patients (6.7%) died in the perioperative
period after the 30 visceral reoperations, both after
first reoperation. One patient died of bowel infarc-
tion on the first postoperative day after undergoing
revision of an occluded aortoceliac prosthetic graft.
The other patient had acute visceral ischemia after
reoperative transaortic endarterectomy of the celiac
artery, SMA, and IMA and ultimately died of sepsis
and multiple organ failure after a prolonged inten-
sive care unit course.
Significant morbidity was noted among 10 of the
30 patients who underwent visceral reoperation
(33.3%). Complications included dissection and
thrombosis of an IMA endarterectomy requiring
reoperation, sepsis (n = 2), bleeding requiring reop-
eration (n = 2), intraabdominal abscess, pancreatitis,
splenic laceration requiring splenectomy, prolonged
ileus, lower extremity deep venous thrombosis, and
respiratory failure requiring reintubation.
Follow-up. Follow-up from visceral reoperation
averaged 80 months and ranged from 1.5 to 188
months. One patient was found to have an asympto-
matic occlusion of her repair on routine postopera-
tive angiography and underwent a second reopera-
tion during the same hospitalization. Symptoms of
visceral ischemia recurred in six (27.3%) of 22
patients 2 weeks to 24 months after first visceral
reoperation. Three of the six patients underwent a
second reoperation and subsequently had no symp-
toms or had significant improvement. One of the six
patients underwent two additional reoperations,
after which she had no symptoms. Two patients with
recurrent visceral ischemic symptoms did not under-
go further revascularization. Arteriography showed
occlusion of an SMA bypass but a widely patent
IMA endarterectomy in one patient who was moni-
tored conservatively. Her postprandial pain resolved,
Fig. 1. Conversion of failed visceral endarterectomy to
antegrade aortovisceral bypass. A, Recurrent stenosis of
celiac artery and occlusion of SMA after transaortic
endarterectomy. Note overlying scar and blood supply
from collateral sources (arrows). B, Revascularization with
bifurcated Dacron graft anastomosed end–to–end to celi-
ac and SMA. Note proximal anastomosis to supraceliac
aorta above scar.
Fig. 2. Revascularization after failed antegrade aortovis-
ceral bypass with distal end–to–side anastomosis. A,
Occluded aortoceliac/SMA Dacron graft with blood sup-
ply from collateral sources. B, After careful dissection
through overlying scar, transaortic endarterectomy is per-
formed with trapdoor aortotomy. Old graft is removed
with patch angioplasty to repair distal anastomotic sites.
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and she had no symptoms 7 years later. The other
patient had no symptoms for 24 months after reop-
eration when acute abdominal pain developed. He
died despite extensive resection of ischemic bowel.
Overall, the cumulative symptom-free survival rate
was 77.3% at 1 year and 62.8% at 5 years after vis-
ceral reoperation.
Two patients were referred after undergoing
multiple visceral operations at other institutions.
One patient underwent her second and third reop-
erations at UCSF. After her third reoperation she
had no symptoms and died of lung cancer 6 years
later. The other patient was referred after three vis-
ceral operations and underwent a third reoperation
with antegrade bypass grafting to the celiac artery
and SMA and transaortic endarterectomy of the
IMA. Seven months later she had recurrent symp-
toms resulting from occlusion of the SMA bypass,
which was successfully managed by percutaneous
transluminal angioplasty and urokinase infusion. She
has required two additional percutaneous interven-
tions and has no symptoms nearly 10 years later.
Survival data by life table analysis of the 90
patients with nonrecurrence who underwent prima-
ry visceral revascularization only at UCSF and of
the 24 patients who underwent visceral reoperation
is displayed in Fig. 3. The cumulative survival rate
at 5 years after primary visceral revascularization
was 61.9% and at 5 years after visceral reoperation
was 74.6%.
Factors associated with recurrent visceral
ischemia. To identify clinical variables associated
with the development of recurrent visceral ischemia,
the 90 patients who underwent primary visceral
revascularization and did not have recurrent visceral
ischemia were compared with the 19 patients who
underwent primary visceral revascularization at
UCSF and later had recurrent visceral ischemia
(acute or chronic). At the time of initial presentation
patients who later had recurrent ischemia lost signif-
icantly more weight (35.1 ± 19.3 pounds vs 22.5 ±
16.4 pounds; p = 0.009) and tended to be younger
(57.7 ± 12.0 vs 63.1 ± 10.6 years; p = 0.05) than
patients who did not have recurrent ischemia. Fac-
tors such as sex, tobacco use, and diabetes mellitus
did not differ between the groups.
When factors at the initial operation were com-
pared, no difference was found between the groups
with respect to the frequency of celiac, SMA, or
IMA repairs, the operative technique (antegrade
bypass, transaortic endarterectomy, or other), the
surgeon performing the operation, or the incidence
of postoperative complications. The only factor asso-
ciated with failure of primary visceral revasculariza-
tion was intraoperative modification of the intended
revascularization procedure as specified by the sur-
geon in the operative note. By this criteria the pri-
mary operative technique was modified in 36.8% of
operations in the recurrent group and in 12.2% of
operations in the nonrecurrent group (p = 0.02).
Although no significant difference was found
between the UCSF recurrent and nonrecurrent
groups in the number of visceral arteries that under-
went revascularization at primary operation (p >
0.5), when all 24 patients who underwent reopera-
tion (including referral patients) were compared
with the nonrecurrent group, the difference became
significant. The mean number of vessels that under-
went revascularization at original operation was sig-
nificantly less in the 24 patients who underwent
reoperation (1.5 ± 0.5) than in the nonrecurrent
group (1.9 ± 0.6; p = 0.004).
DISCUSSION
It is well established that operative visceral revas-
cularization can effectively correct chronic visceral
ischemia. Yet despite the overall success most series
have reported late failures. Zelenock et al.7 reported
an overall failure rate of 34% in their series of 23
patients, most of whom underwent visceral artery
bypass grafting procedures. Hollier et al.6 reported
an overall late recurrence rate of 27%, which was
Fig. 3. Life table analysis of postoperative survival after
primary visceral revascularization for chronic visceral
ischemia (n = 90) or reoperation for recurrent chronic vis-
ceral ischemia (n = 24). For reoperation patients’ survival
is calculated from date of first reoperative procedure per-
formed at UCSF. Number of patients available for follow-
up at 60 and 120 months is indicated. Standard error is
less than 10% at all points.
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inversely correlated with the number of visceral
arteries that underwent revascularization. More
recently, Johnston et al.16 reported graft thrombosis
in 14% of 21 patients who underwent elective vis-
ceral artery bypass grafting. McMillan et al.3 used
duplex ultrasonography to assess the patency of vis-
ceral artery grafts and reported a 3-year graft failure
rate of 11%.
Our cumulative experience with the surgical
management of chronic visceral ischemia confirms
that recurrent ischemia is not uncommon. Recur-
rence was documented in 17.4% out of 109 patients
who underwent primary visceral revascularizations at
UCSF. Patients who had recurrent visceral ischemia
fell into two distinct categories with strikingly differ-
ent outcomes. One third of patients had recurrent
acute visceral ischemia, and 85.7% of these patients
died of bowel infarction. Recurrent acute ischemia
was uniformly fatal in the perioperative period, in
agreement with previous reports.5-7,17 In contrast,
two-thirds of the patients with recurrent visceral
ischemia had symptoms of chronic visceral ischemia.
When compared with patients with recurrent acute
ischemia, patients with recurrent chronic visceral
ischemia had better outcomes. Rapid recognition of
the symptoms of chronic visceral ischemia and revas-
cularization before the development of bowel infarc-
tion apparently contributed to the improved out-
come in this group of patients.
Additional improvement in outcome after visceral
revascularization might be realized by identifying
patients who are at increased risk for recurrent visceral
ischemia. We found that patients who later went on to
have recurrent intestinal ischemia lost more weight
before their primary visceral revascularization proce-
dure compared with patients in our series who did not
have recurrent ischemia (Table IV). There also
appeared to be an association between recurrent vis-
ceral ischemia and younger age at primary visceral
revascularization. Other groups have also observed the
development of acute visceral ischemia in younger
patients after primary visceral revascularization.7,17
This finding may indicate that a subgroup of patients
has a more aggressive disease process that initially pre-
sents at an earlier age and is apt to recur sooner. In
addition, premature atherosclerosis is thought to be
associated with hypercoaguability,18-20 which was doc-
umented in two of our patients with recurrent acute
visceral ischemia and aortovisceral graft thrombosis.
Controversy currently exists regarding the num-
ber and priority of visceral vessels that should under-
go revascularization at primary operation. Hollier et
al.6 suggested that the frequency of recurrent viscer-
al ischemia was inversely related to the number of
visceral vessels that underwent revascularization and
reported recurrence rates of up to 50% when only
one artery underwent revascularization. Many inves-
tigators promote revascularization of at least the
celiac artery and SMA at primary operation on the
basis of similar observations.16,21,22 However, this
view has been challenged by reports from other
groups that describe low mortality and recurrence
rates after isolated bypass grafting to the SMA.23,24
Our preferred approach is to perform revasculariza-
tion on both the celiac artery and SMA, which may
explain why we were unable to detect a difference in
the number of vessels repaired at primary operation
between the UCSF recurrent and UCSF nonrecur-
rent groups. When we compared all patients with
recurrence including patients who underwent pri-
mary operations elsewhere with the nonrecurrent
group, the number of visceral arteries that under-
went revascularization at the primary operation was
significantly lower in the recurrent group. Although
these results suggest that complete revascularization
at primary operation may prevent recurrent visceral
ischemia, the differences in outcome must be inter-
preted with caution. The observed difference could
be the result of factors other than the number of ves-
sels that underwent revascularization, because the
primary operations were performed by different sur-
geons at multiple hospitals.
Most of the patients in this series underwent vis-
ceral reoperation with the same techniques that we
routinely use for primary visceral revascularization.2
Antegrade aortovisceral bypass grafting or transaor-
tic thromboendarterectomy was performed in 20
(90.9%) of the 22 first reoperations. Selection of the
revascularization technique was based on the tech-
nique used for previous revascularization. Typically,
antegrade bypass grafting was used to repair a previ-
ously endarterectomized artery and, conversely,
endarterectomy was often used to manage a failed
bypass graft (antegrade or retrograde). Combina-
tions of these two techniques were used in the
remaining two first (9.1%) reoperations. Scarring
caused by multiple operations or previous
end–to–end anastomosis to major visceral arteries
precluded the use of endarterectomy in all but one
of the eight second or third reoperations. Aortovis-
ceral bypass grafting or local revision of a previous
repair was performed in these cases. Occasionally
revascularization of the IMA alone was successful
when revascularization could not be performed in
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other major visceral arteries. In most of the cases we
found that the same operative techniques used for
primary visceral revascularization could be applied to
convert a failed repair to a successful revasculariza-
tion. Moreover, transaortic visceral endarterectomy
was safely and effectively used in the reoperative set-
ting.
In-hospital deaths occurred after 6.7% of the 30
reoperations for chronic visceral ischemia and were
caused by graft failure resulting in bowel necrosis.
Complications were observed in one third of
patients. Although such mortality and complication
rates are not trivial, they are comparable with results
reported after primary visceral revasculariza-
tion.2–6,21,22,24,25 It is interesting that the incidence
of complications was not less in patients who under-
went visceral reoperation in more recent times and
may reflect an increased frequency of comorbid con-
ditions in this group of patients.
With a mean follow-up of 80 months the cumu-
lative symptom–free survival rate at 5 years was
62.8% in patients who underwent reoperation com-
pared with 86.1% in patients who underwent prima-
ry visceral revascularization at UCSF.2 Despite the
slightly higher rate of recurrence after visceral reop-
eration, most patients eventually had improvement
after an additional reoperation. After reoperation for
recurrent chronic visceral ischemia was performed,
the long-term survival rate was 74.6% compared
with 61.9% after primary visceral revascularization.
Thus our long-term results with secondary visceral
revascularization approach those achieved with pri-
mary visceral revascularization.2-6,21,22,24,25
Given the likelihood that without revascular-
ization most patients with chronic visceral
ischemia symptoms will progress to fatal visceral
infarction26 and the favorable outcome after
repeat visceral revascularization, it would be ideal
to identify patients with failing grafts before they
have symptoms of visceral ischemia. Mesenteric
duplex scanning can accurately assess visceral ves-
sels after endarterectomy or bypass grafting and
may allow the detection of asymptomatic stenoses,
allowing elective reoperation before visceral
ischemia develops.3,27 We now routinely monitor
patients who undergo visceral revascularization
with mesenteric duplex scanning after operation.
When recurrence is detected by duplex scanning
or suggested by the reappearance of symptoms,
biplanar aortography is obtained to facilitate plan-
ning for the secondary visceral revascularization.
CONCLUSION
On the basis of our experience with the surgical
management of recurrent chronic visceral ischemia,
we conclude that recurrent visceral ischemia after
primary visceral revascularization is not uncommon.
Although recurrent acute visceral ischemia is associ-
ated with a high mortality rate because of bowel
infarction, patients with recurrent chronic visceral
ischemia may be successfully treated with repeat vis-
ceral revascularization. The established techniques
of transaortic visceral endarterectomy and aortovis-
ceral bypass grafting can both be used in the reoper-
ative setting, and the selection of either technique
should be based on the type of previous revascular-
ization used. Because the incidence of recurrent vis-
ceral ischemia may be influenced by the complete-
ness of primary visceral revascularization, we recom-
mend revascularization of both the celiac and the
SMA. Finally, additional studies are required to
determine whether routine duplex scanning after
visceral revascularization can identify asymptomatic
recurrent visceral ischemia and improve long-term
survival rates.
Jerry Goldstone, MD, contributed several patients to
this series. We thank Andrea Lemmo, BSN, for assistance
with data collection and patient follow–up.
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DISCUSSION
Dr. Gerald B. Zelenock (Ann Arbor, Mich.). I would
like to offer my congratulations to Dr. Schneider and the
San Francisco group for their excellent, well-written, and
well-presented article and my thanks for the opportunity
to discuss this work. This topic is important for several rea-
sons. Their report of 33 patients with recurrent visceral
ischemia, including 24 with chronic recurrent visceral
ischemia, forms the largest review of this particular prob-
lem to date. Their carefully studied patient population
provides some reasonable practice guidelines for us all.
It is important to note that mesenteric vascular dis-
ease causing visceral ischemia remains a persistent prob-
lem in clinical practice and is often underappreciated
and distressingly slow to be recognized or considered
even when multiple diagnostic studies have been under-
taken and do not identify an underlying cause of the
patient’s symptoms. In our experience at Michigan, 6 to
7 months of diagnostic studies have often been under-
taken before the patient is referred for evaluation often
with an acute or a subacute abdominal crisis. This is cer-
tainly true in the initial presentation of patients with
mesenteric vascular disease and appears also to be some-
what of a factor in the patients with recurrent disease.
Dr. Schneider’s report also outlines the enormous dif-
ferences between acute recurrent visceral ischemia and
chronic recurrent visceral ischemia. The latter has a quite rea-
sonable mortality rate of 6.7%, and this is a particularly excel-
lent result given the complexity of secondary and tertiary
reconstructions. However, acute recurrent visceral ischemia
has a mortality rate of fully 86% even in the hands of these
very experienced surgeons and underscores the need for
promptly making a diagnosis and undertaking therapy.
The authors carefully point out the need for a thor-
ough grounding in all of the various techniques of viscer-
al revascularization. Their experience emphasizes the need
for familiarity with the multiple approaches and tech-
niques, because no one technique is appropriate or usable
in all circumstances. The article also highlights the impor-
tance of persistence. Twenty-seven percent of their
patients undergoing a first reoperation had recurrent
symptoms, half of which were cured by a third or a fourth
operation. Their overall results were exceptional for
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patients with chronic recurrent visceral ischemia with a
life-table survival rate of 75% at 5 years and symptom-free
survival of 77% and 63% at 1 and 5 years. I have only two
questions for the authors.
Do you have information regarding the interval from
onset of symptoms to diagnosis and definitive therapy for
your patients with recurrent visceral ischemia, and how
does that compare with the same interval in your 109
patients with primary visceral revascularization? And two,
given your recognition of hypercoagulable states, particu-
larly in the younger patients, are they now recommending
routine postoperative anticoagulation in these patients?
Again, my congratulations to the San Francisco group
for their excellent results and their clear and well-present-
ed report.
Dr. Darren B. Schneider. Thank you for your kind
comments, Dr. Zelenock. With regard to your first ques-
tion about the interval from the onset of symptoms to the
diagnosis of primary visceral ischemia, I agree with what
you have said. Patients with primary visceral ischemia
tended to have a delay from the development of symptoms
to diagnosis and reoperation of approximately 12 months.
In contrast, probably because of their history of a visceral
revascularization, patients with recurrent visceral ischemia
were given diagnoses much earlier. Their interval to diag-
nosis of recurrent ischemia averaged 3 months, and in
many cases it was much shorter.
With regard to whether patients with acute visceral
ischemia should undergo routine anticoagulation, I do not
believe that has been determined. It is interesting that two
of the seven patients with acute recurrence of their viscer-
al ischemia did have hypercoagulable syndromes. Because
this was a retrospective review, I do not know what the
actual incidence of hypercoagulable conditions was. More
than one half of the patients with acute recurrence were in
their 40s, and they may belong to a subpopulation of
patients with premature atherosclerosis associated with
hypercoagulability. It is possible that this subgroup of
patients would benefit from anticoagulation.
Dr. Kenneth J. Cherry Jr. (Rochester, Minn.). I
would like to congratulate Dr. Schneider for an excellent
article and excellent presentation. Dr. Schneider, I have a
few questions for you if I could.
In retrospect, do you have any idea how many patients
had asymptomatic reconstructive failures? You may well
not, because I know many of these predated the advent of
duplex surveillance scanning. Also, in retrospect, are any
of the patients who had acute exacerbations, or were any
of those patients? I know they did not have any formal
reconstructions. Could they have had, was there a window
of opportunity there in which they might have had a for-
mal reconstruction?
The next question is, were you able to determine the
cause of the failure? Was it an anastomotic problem, or was
it progression of atherosclerosis in the recipient vessels? We
have seen that in a number of patients actually with patent
grafts but extension of their atherosclerosis. And although
you report that the results are comparable, there is a 27% fail-
ure rate within 2 years. And I am making the assumption it
is because the reconstruction had to be carried to a much
more distal site on the main mesenteric vessels, or indeed to
branches, and I wondered whether that were the case.
Dr. Schneider. Thank you, Dr. Cherry. With regard
to your first question about asymptomatic occlusions, we
do not have any data on this subject because many of the
operations were before the introduction of mesenteric
duplex scanning. The study by McMillan from the North-
western group has clearly shown that grafts may be objec-
tively followed with mesenteric duplex scanning. Current-
ly, we are following our patients with mesenteric duplex
scanning.
Regarding recurrent acute visceral ischemia and
whether these patients may be revascularized, in our expe-
rience these patients usually presented with bowel infarc-
tion. None of the seven patients underwent a formal revas-
cularization. Thrombectomy was attempted but was
unsuccessful in two patients. The lone surviving patient
had a patent visceral revascularization but an isolated seg-
ment of jejunum that was infarcted and was resected.
It is true that 27% of our patients had recurrence after
visceral reoperation. This may reflect a selection bias
because patients with recurrent visceral ischemia may have
a more aggressive type of atherosclerosis.
I do not know the cause of recurrence in all our cases.
We suspect that many early recurrences are the result of
technical failures, whereas late recurrences appear to be
caused by progressive atherosclerotic disease.
Dr. Walter J. McCarthy III (Chicago, Ill.). I rise to
congratulate the authors on their presentation today and
also for their innovative leadership in this area over the last
3 decades. Our experience at Northwestern also advocates
a comprehensive revascularization for patients with chron-
ic ischemia, for which we preferentially use saphenous vein
grafts to both the SMA and the celiac and sometimes to
the inferior mesenteric arteries. Recently we reviewed this
cohort and found that the patency of these grafts was 89%
with a 6-year follow-up. We detected, with a duplex sur-
veillance program, several patients who had one graft that
had occluded but the other one was still patent, keeping
them asymptomatic. None of those patients has presented
with bowel ischemia in the surveillance period. I just have
two questions for the authors.
Can you speculate from your follow-up on recurrence
rates comparing endarterectomy and bypass graft revascu-
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larization? Second, can you tell us who the younger
patients are, and why do you think they are recurring
early?
Dr. Schneider. Thank you for your comments, Dr.
McCarthy. It is difficult to determine whether recurrence
was more frequent after endarterectomy or bypass because
many of the patients underwent their original operations
at other hospitals. Most of the patients referred underwent
visceral bypass at their primary operation. Among the
UCSF group there were similar numbers of patients who
originally underwent endarterectomy or bypass. Several of
these patients underwent operations that are no longer
used at UCSF including transarterial endarterectomy and
bypass with saphenous vein. Currently, our preferred con-
duit is Dacron, but we have not found a significant associ-
ation between the choice of conduit and recurrence.
Patients with acute ischemia were younger, and it is
possible that this is because they have a more aggressive
variant of atherosclerosis. Other conditions such as hyper-
coagulability may also contribute to recurrence by causing
thrombosis of visceral repairs. This appeared to be the case
with two of our patients who presented with recurrent
acute visceral ischemia.
Dr. Robert B. Smith III (Atlanta, Ga.). I think we all
admire the San Francisco group for their breadth of expe-
rience in this area. It is interesting that their recurrences
were diagnosed, on the whole, more promptly than the
original illness. We, in fact, have had patients at Emory
perceptive enough to come back and report that “I have
the same condition again.” Of course, that eliminates
some of the diagnostic studies. I have two questions.
The first relates to the management of the occluded
graft. Have you had experience with urokinase, with or
without balloon angioplasty, as a way to try to reopen the
graft short of a big operation? You have shown excellent
morbidity and mortality on your elective reoperations, but
there is no question that it is a sizable undertaking.
The second question is an inference from some of the
things we have heard about asymptomatic occlusions. The
admonition in the literature is to perform multiple revas-
cularizations on the first occasion so that if one fails, the
other will maintain the patient. One would infer then that
it is okay to accept one graft failure as long as the patient
has no symptoms. Would that be your interpretation as
well, or would you feel that a failed superior mesenteric
artery graft puts the patient at greater risk and should be
addressed?
Dr. Schneider. Dr. Smith, with regard to your first
question, one patient in our series underwent three viscer-
al reoperations and later presented with occlusion of a
bypass graft to the SMA. She was successfully treated with
angioplasty and urokinase infusion. She has had two addi-
tional angioplasties and has no symptoms 10 years after
her third visceral reoperation. Based on this limited expe-
rience, angioplasty and urokinase may be a viable alterna-
tive in selected cases.
In terms of accepting failure of one graft as long as the
other remains patent, that is the idea behind revasculariz-
ing both major visceral vessels. Of course, we prefer that
all grafts remain patent. When a graft fails, I do not know
whether it is more important that the celiac or the SMA
remains patent. Although there is greater blood flow
through the SMA, we have been successful in revascular-
izing only the celiac artery in several patients when that
was all that was possible.
